Acerus Pharmaceuticals Corporation announced earnings results for the first quarter ended March 31, 2020. For the first quarter, the company announced operating loss was USD 4.255 million compared to USD 3.743 million a year ago. Net loss was USD 4.663 million compared to USD 4.431 million a year ago. Basic loss per share from continuing operations was USD 0.01 compared to USD 0.02 a year ago.